iifl-logo

Orchid Pharma Ltd Annually Results

810.05
(-3.04%)
Apr 30, 2025|02:49:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

819.37

665.9

559.56

450.06

483.81

Excise Duty

0

0

0

0

0

Net Sales

819.37

665.9

559.56

450.06

483.81

Other Operating Income

0

0

0

0

0

Other Income

30.86

58.64

67.47

15.23

24.28

Total Income

850.23

724.54

627.03

465.29

508.09

Total Expenditure

708.69

589.06

506.42

421.56

517.03

PBIDT

141.54

135.48

120.61

43.72

-8.94

Interest

16.35

32.23

32.01

51.34

4.16

PBDT

125.18

103.26

88.6

-7.61

-13.1

Depreciation

33.24

54.79

87.02

108.92

117.93

Minority Interest Before NP

0

0

0

0

0

Tax

0.11

0

0

0

0

Deferred Tax

-3.23

0

0

0

0

Reported Profit After Tax

95.06

48.47

1.57

-116.53

-131.03

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

92.17

46.32

-1.95

-116.53

-131.03

Extra-ordinary Items

0

32.44

58.47

0

0

Adjusted Profit After Extra-ordinary item

92.17

13.88

-60.42

-116.53

-131.03

EPS (Unit Curr.)

19.06

11.35

-0.48

-28.55

-32.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

40.82

40.82

40.82

40.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

17.27

20.34

21.55

9.71

-1.84

PBDTM(%)

15.27

15.5

15.83

-1.69

-2.7

PATM(%)

11.6

7.27

0.28

-25.89

-27.08

Orchid Pharma: Related NEWS

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal
20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.